Supplementary Table S1 from INDUCE-3: A Randomized Phase II/III Study of First-line Feladilimab plus Pembrolizumab in Patients with Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma
Year: 2026
Type: supplementary-materials
Abstract: Representativeness of study participants
Authors: Danny Rischin, Aaron R. Hansen, Ezra E.W. Cohen, Makoto Tahara, Kevin J. Harrington, Robert I. Haddad, Lisa Licitra, Hisham Mehanna, Robert L. Ferris, Piotr Koralewski, Konstantin Penkov, Michael Schenker, David R. Spigel, Amaury Daste, Min Hee Hong, Ye Guo, Michael J. Chisamore, Michael L. Washburn, Amy Phillips‐Jones, John Russell, Sumita Roy‐Ghanta, Catherine Ellis, Marc Ballas, Christophe Le Tourneau
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
OpenAlex ID: W7136101734